Isogambogenic acid
CAS No. 887923-47-9
Isogambogenic acid( —— )
Catalog No. M31205 CAS No. 887923-47-9
Isogambogenic acid inhibits angiogenesis and may be a viable drug candidate in anti-angiogenesis therapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIsogambogenic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsogambogenic acid inhibits angiogenesis and may be a viable drug candidate in anti-angiogenesis therapy.
-
DescriptionIsogambogenic acid inhibits angiogenesis and may be a viable drug candidate in anti-angiogenesis therapy. Isogambogenic acid exhibits an anticancer effect by inducing autophagy-dependent cell death in NSCLC cells, which may be an effective chemotherapeutic agent that can be used against NSCLC in a clinical setting.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorBcl-2/Bax | Caspase | mTOR | VEGFR | Akt | MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number887923-47-9
-
Formula Weight630.8
-
Molecular FormulaC38H46O8
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
[D-Ala4]-Substance P...
[DAla4] Substance P (4-11) is an analog of Substance P (Substance P ) that inhibits the binding of 125I-Bolton Hunter-conjugated Eledoisin (Eledoisin) (IC50 of 0.5 μM) and 125I-Bolton Hunter-conjugated Substance P (IC50 of 0.15 μM) to rat brain cortex membranes.
-
Heteroclitin G
Heteroclitin G was found as potential biomarkers of KIS blood-replenishing activity, and quantitative analysis provided a research basis for further pharmacological research.
-
8-Prenylkaempferol
8-Prenylkaempferol is an effective agent for attenuating pro-inflammatory NO induction, it may be an anti-inflammatory agent for suppressing influenza A virus-induced RANTES production acts by blocking PI3K-mediated transcriptional activation of NF-κB and IRF-3 and in part by interfering with IκB degradation which subsequently decreases NF-κB translocation.
Cart
sales@molnova.com